ALPROSTADIL for Heart disease congenital: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 29 adverse event reports in the FDA FAERS database where ALPROSTADIL was used for Heart disease congenital.
Most Reported Side Effects for ALPROSTADIL
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 1,412 | 50.4% | 5 | 27 |
| Wrong technique in product usage process | 510 | 18.2% | 0 | 5 |
| Product quality issue | 227 | 8.1% | 0 | 10 |
| Penile pain | 164 | 5.9% | 0 | 7 |
| Off label use | 112 | 4.0% | 8 | 31 |
| Penile burning sensation | 92 | 3.3% | 0 | 2 |
| Erection increased | 75 | 2.7% | 0 | 5 |
| Penile haemorrhage | 62 | 2.2% | 0 | 1 |
| No adverse event | 60 | 2.1% | 0 | 0 |
| Injection site pain | 57 | 2.0% | 0 | 1 |
| Expired product administered | 52 | 1.9% | 0 | 3 |
| Priapism | 50 | 1.8% | 0 | 15 |
| Therapeutic product effect incomplete | 47 | 1.7% | 0 | 0 |
| Product use issue | 44 | 1.6% | 6 | 5 |
| Pain | 43 | 1.5% | 1 | 2 |
Other Indications for ALPROSTADIL
Erectile dysfunction (1,641)
Product used for unknown indication (319)
Prophylaxis (38)
Patent ductus arteriosus (26)
Hypoplastic left heart syndrome (12)
Prostate cancer (12)
Sexual dysfunction (11)
Peripheral ischaemia (8)
Ventricular septal defect (8)
Peripheral arterial occlusive disease (7)
Other Drugs Used for Heart disease congenital
AMBRISENTAN (772)
PALIVIZUMAB (546)
BOSENTAN (65)
MACITENTAN (56)
LETAIRIS (39)
TREPROSTINIL (35)
SILDENAFIL (28)
SYNAGIS (28)
NITRIC (18)
RIOCIGUAT (16)